Management of gout in chronic kidney disease: a G-CAN Consensus Statement on the research priorities

Lisa K Stamp1, Hamish Farquhar2, Huai Leng Pisaniello3

  • 1University of Otago, Christchurch, New Zealand. Lisa.Stamp@cdhb.health.nz.

Insights

Managing gout in patients with chronic kidney disease (CKD) is challenging due to limited evidence and conflicting recommendations. This consensus statement highlights research gaps for effective gout and CKD management.

Area of Science:

  • Nephrology
  • Rheumatology
  • Clinical Pharmacology

Background:

  • Gout and chronic kidney disease (CKD) frequently coexist, creating management challenges.
  • Current evidence guiding gout management in CKD patients is limited, leading to varied treatment approaches.
  • Conflicting professional recommendations exacerbate confusion among clinicians regarding gout and CKD treatment.

Framework:

  • This consensus statement by the Gout, Hyperuricemia and Crystal-Associated Disease Network (G-CAN) analyzes existing evidence on gout management in CKD.
  • It identifies critical research gaps concerning both general management strategies and specific urate-lowering therapies (ULTs) and flare treatments.
  • The statement is supported by G-CAN systematic literature reviews, focusing on safety and efficacy data.

Implementation:

  • The document critically examines the use of urate-lowering therapy (ULT) in advanced CKD.
  • It discusses the safety and efficacy of various medications used for gout flares and ULT.
  • Key areas for future research are identified to address the lack of robust evidence.

Implications:

  • Clarifies the current state of knowledge regarding gout management in CKD patients.
  • Provides a research agenda to guide future studies on optimal treatment strategies.
  • Aims to reduce clinical confusion and improve patient care for those with coexisting gout and CKD.

Related Concept Videos

Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
154
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
99
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
87
Urinary Tract Calculi III: Medical Management01:30

Urinary Tract Calculi III: Medical Management

The diagnosis of renal calculi involves several imaging techniques, including non-contrast CT scans and ultrasound. These methods help visualize kidney stones, assess their size and location, and detect possible obstructions. Additionally, Measuring urine pH is useful for diagnosing specific stone types, such as struvite (alkaline pH) and uric acid stones (acidic pH). Cystine stones are primarily linked to cystinuria, a genetic condition. A urinalysis helps detect blood in the urine (hematuria)...
58
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
102
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
193